Penumbra, Inc.

02/04/2026

🎉 Ruby XL earns both the Innovation Award (Vascular Solutions) and Product Launches Award (Endovascular Devices) at the 2025 Medical Device Network Excellence Awards. Read more here: https://peninc.info/4atZepk

01/29/2026

Inspired by storytelling, Juliana Monela Teter turns complex clinical innovation into meaningful, human‑centered narratives. Discover how creativity, collaboration, and a drive to take on challenging projects fuel her growth and help bring life‑saving work to light. Read more here: https://peninc.info/4a3qrOu. Interested in joining our team? Explore career opportunities: https://bit.ly/3z6E0Kx

01/23/2026

Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy system. Read more here: https://peninc.info/4bbz3Vm

01/22/2026

Don't miss our upcoming webinar featuring A/Prof. GuangMing Tan, A/Prof. Rachel Rosovsky, A/Prof. Too Chow Wei and Dr. Arvin Rajadurai. As new evidence continues to shape pulmonary embolism management, join these experts to discuss evolving referral patterns and the future of PE care. Register now: https://event.on24.com/wcc/r/5168112/26C45E5AAE079251625EA9EC1EF0D5C0?partnerref=FB

01/15/2026

Today, we announced an agreement that Boston Scientific will acquire Penumbra, Inc. By combining Penumbra’s innovative technologies with Boston Scientific’s global commercial footprint, we can expand access to the latest therapies for more people around the world suffering from serious conditions like blood clots or aneurysms. Click here to learn more:

Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases Provides scaled entry into mechanical thrombectomy and...

01/12/2026

Penumbra is presenting at the J.P. Morgan 44th Annual Healthcare Conference today at 6:45pm ET / 3:45pm PT. A webcast of the presentation can be accessed on our website: https://peninc.info/4qDKdqh.

12/23/2025

This holiday season, we’re grateful for all those who drive our innovation forward. Wishing you a wonderful holiday season and a happy New Year!

12/19/2025

US HCPs: A recently published study in the American Journal of Cardiology found that CAVT may help hospitals reduce length of stay, lower complications, and support better outcomes for patients with intermediate-risk PE. Read more on how could benefit hospital systems and improve patient outcomes: https://peninc.info/4oZZLDF

Rx only. Risk info: http://peninc.info/risk Clinical results may vary.

11/25/2025

Hear from Dr. Lookstein, Co-Principal Investigator of the -PE , as he discusses the study’s primary endpoints and what these results mean for advancing PE treatment. Learn more here: https://www.penumbrainc.com/storm-pe-rct/

11/25/2025

From adrenaline-filled adventures to everyday impact, Lily Lim thrives on challenges that make a difference. Discover how this senior territory manager combines bold choices with a passion for improving lives. Read more here: https://peninc.info/4rsYBDd. If you’d like to join our team, visit https://bit.ly/3z6E0Kx to learn more about career opportunities.

11/20/2025

US HCPs: He faked a heart attack to save his life. Now he’s helping change how we treat pulmonary embolism.

Read Richard Davis’s story of survival, advocacy, and impact on the STORM-PE RCT trial: https://peninc.info/43INYBI

11/11/2025

US HCPs: New analyses from the STRIKE-PE study presented at show that CAVT technology was associated with improved functional outcomes and quality of life for patients with intermediate- and high-risk pulmonary embolism. Read more about the findings here: https://peninc.info/3WSQ4v9

Rx only. Risk info: http://peninc.info/risk Clinical results may vary.